NEPTAZ contains a [complex, comprised of Sacubitril and Valsartan, in a specific molar ratio
Mankind Pharma’s heart failure drug, NEPTAZ, which is manufactured using US FDA approved DMF grade API, has been priced at 70 per cent lesser price.
The company has announced a price reduction of up to 70 per cent across different SKUs for its brand NEPTAZ (Sacubitril/Valsartan). This price reduction is expected to make NEPTAZ affordable to Indian patients. Mankind [launched NEPTAZ in the year 2022] under a [collaboration agreement] with [Novartis.]
NEPTAZ contains a [complex, comprised of Sacubitril and Valsartan, in a specific molar ratio. Both these medicines work synergistically to reduce hospitalisation as well as mortality in patients with chronic heart failure.
